| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_878fa4779ff99c8b60b83532389894e7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10a484484c6a4a19d44a8bfc306291b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37a414820cf8a415c31e72c37e84b0a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e226ae0c21834aadc8805374da05625 |
| publicationDate |
2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120104574-A |
| titleOfInvention |
Combination of Tibozanib and temsirolimus |
| abstract |
Disclosed are methods of treating tumors in human patients. The method comprises co-administering a patient with a dose of (a) 1.5 mg / day of tibozanib and (b) 25 mg / week of temsirolimus. In some embodiments of the invention, tibozanib is administered in a dose once per day for three weeks, followed by a repeated schedule that is not administered for one week. In particular, the disclosed methods are suitable for the treatment of renal cell carcinoma. |
| priorityDate |
2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |